Get the Stockscreener App
7.72
4.00%
-0.29
After Hours:
7.71
-0.010
-0.13%
Foghorn Therapeutics Inc Stock (FHTX) Forecast
The Foghorn Therapeutics Inc (FHTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.6553, representing a -78.56% decrease from the current price of $7.72. The highest analyst price target is $3.2917, and the lowest is $0.0188.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FHTX Price Target
Average 8.1566
(+5.66% Upside)
Is Foghorn Therapeutics Inc (FHTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.46 | Neutral |
| STOCH(9,6) | 48.41 | Neutral |
| STOCHRSI(14) | 53.00 | Neutral |
| MACD(12,26) | 0.1029 | Sell |
| ADX(14) | 21.61 | Neutral |
| William %R | -83.97 | Buy |
| CCI(14) | -120.14 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.815
Sell
|
8.4781
Sell
|
| MA20 |
8.358
Sell
|
8.4203
Sell
|
| MA50 |
8.497
Sell
|
8.1774
Sell
|
| MA100 |
7.5179
Buy
|
7.6892
Buy
|
| MA200 |
6.7892
Buy
|
7.0605
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, FHTX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on FHTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.46 indicates that FHTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.41 indicates that FHTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 53 indicates that FHTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.61 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -120.14 indicates that FHTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term FHTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Foghorn Therapeutics Inc financial reports and earnings history, Foghorn Therapeutics Inc (FHTX) stock could reach $3.9809 by 2030, $8.8001 by 2040 and $35.74 by 2050. See the projected annual prices until 2050 of the Foghorn Therapeutics Inc stock below:
- Foghorn Therapeutics Inc (FHTX) is expected to reach an average price of $10.75 in 2035, with a high prediction of $10.88 and a low estimate of $10.37. This indicates an $39.24% rise from the last recorded price of $7.72.
- Foghorn Therapeutics Inc (FHTX) stock is projected to chart a bullish course in 2040, with an average price target of $9.4751, representing an $22.73% surge from its current level. The forecast ranges from a conservative $8.4716 to a sky-high $8.8001.
- Our analysts predict Foghorn Therapeutics Inc (FHTX) to jump 407.70% by 2045, soaring from $40.48 to an average price of $39.19, potentially reaching $42.80. While $40.48 is the low estimate, the potential upside is significant.
- Foghorn Therapeutics Inc (FHTX) stock is expected to climb by 2050, reaching an average of $34.85, a $351.39% jump from its current level. However, a wide range of estimates exists, with high and low targets of $35.74 and $35.12, respectively, highlighting the market's uncertainty.
Foghorn Therapeutics Inc Stock (FHTX) Year by Year Forecast
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2024
Our forecast for FHTX stock price in 2024 now indicates an average price target of $9.1903 with a high forecast of $18.36 and a low forecast of $0.0188. The average prediction reflects an increase of +19.05% from the last recorded price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $2.7217 | $0.0188 | $3.2917 | -64.74% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2025
Foghorn Therapeutics Inc Stock (FHTX) is expected to reach an average price of $8.1619 in 2025, with a high prediction of $16.29 and a low estimate of $0.0294. This indicates an +5.72% rise from the last recorded price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.3865 | $0.2527 | $3.3327 | -82.04% |
| February, 2025 | $0.3296 | $0.0294 | $1.6575 | -95.73% |
| March, 2025 | $4.2842 | $0.2806 | $4.3542 | -44.51% |
| April, 2025 | $5.394 | $3.4152 | $7.0169 | -30.13% |
| May, 2025 | $4.2829 | $3.2929 | $6.08 | -44.52% |
| June, 2025 | $5.3867 | $3.6448 | $6.3357 | -30.22% |
| July, 2025 | $10.95 | $2.1296 | $11.65 | +41.86% |
| August, 2025 | $9.5953 | $8.3053 | $16.29 | +24.29% |
| September, 2025 | $5.7292 | $4.7248 | $10.30 | -25.79% |
| October, 2025 | $1.264 | $0.844 | $6.3301 | -83.63% |
| November, 2025 | $7.6178 | $0.675 | $8.3569 | -1.32% |
| December, 2025 | $4.1326 | $3.5876 | $9.7148 | -46.47% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2026
The predicted value for Foghorn Therapeutics Inc (FHTX) in 2026 is set at an average of $5.6114. Estimates vary from a peak of $11.19 to a trough of $0.0337, indicating an -27.31% surge from the present price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.7165 | $0.6146 | $6.2865 | -25.95% |
| February, 2026 | $4.7503 | $3.7903 | $8.2594 | -38.47% |
| March, 2026 | $8.4242 | $5.1013 | $8.5042 | +9.12% |
| April, 2026 | $11.08 | $6.7671 | $11.19 | +43.51% |
| May, 2026 | $3.2028 | $2.8328 | $11.09 | -58.51% |
| June, 2026 | $1.8967 | $0.6357 | $3.9547 | -75.43% |
| July, 2026 | $2.2115 | $0.4195 | $2.5347 | -71.35% |
| August, 2026 | $1.0353 | $0.8053 | $3.0743 | -86.59% |
| September, 2026 | $0.5499 | $0.0337 | $1.0663 | -92.88% |
| October, 2026 | $1.744 | $0.082 | $3.693 | -77.41% |
| November, 2026 | $1.4078 | $0.6278 | $3.3168 | -81.76% |
| December, 2026 | $0.5474 | $0.2212 | $1.3488 | -92.91% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Foghorn Therapeutics Inc (FHTX) is $2.4821, with a high forecast of $4.8966 and a low forecast of $0.0676. This indicates an -67.85% decrease from the last price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1365 | $0.0735 | $0.7055 | -98.23% |
| February, 2027 | $0.4503 | $0.0676 | $1.8774 | -94.17% |
| March, 2027 | $1.6551 | $0.4807 | $1.6732 | -78.56% |
| April, 2027 | $1.7189 | $1.5089 | $3.898 | -77.73% |
| May, 2027 | $3.8428 | $1.2499 | $4.0128 | -50.22% |
| June, 2027 | $2.0576 | $1.6777 | $4.8966 | -73.35% |
| July, 2027 | $1.5914 | $1.4114 | $3.0836 | -79.39% |
| August, 2027 | $1.3047 | $0.1234 | $1.7155 | -83.10% |
| September, 2027 | $1.4099 | $1.4599 | $1.3328 | -81.74% |
| October, 2027 | $0.0261 | $0.3761 | $0.179 | -99.66% |
| November, 2027 | $2.0578 | $0.0951 | $2.4978 | -73.34% |
| December, 2027 | $1.0574 | $0.5193 | $2.3337 | -86.30% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2028
In 2028, Foghorn Therapeutics Inc (FHTX) is projected to reach an average price of $4.251, with a high projection of $8.4585 and a low estimate of $0.0435. This indicates an -44.94% fall from the last price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.8664 | $1.3065 | $3.2555 | -75.82% |
| February, 2028 | $1.9203 | $1.792 | $4.3883 | -75.13% |
| March, 2028 | $1.4651 | $1.3051 | $4.1841 | -81.02% |
| April, 2028 | $4.26 | $0.996 | $3.53 | -44.82% |
| May, 2028 | $0.2796 | $1.2623 | $3.8681 | -96.38% |
| June, 2028 | $0.5873 | $0.0435 | $8.4585 | -92.39% |
| July, 2028 | $2.935 | $0.8269 | $5.665 | -61.98% |
| August, 2028 | $5.4154 | $2.7512 | $2.1973 | -29.85% |
| September, 2028 | $5.6977 | $6.2577 | $5.0635 | -26.20% |
| October, 2028 | $6.96 | $6.3158 | $6.39 | -9.84% |
| November, 2028 | $7.9104 | $8.0681 | $8.1943 | +2.47% |
| December, 2028 | $7.7827 | $7.8066 | $6.8685 | +0.81% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2029
The 2029 price forecast for Foghorn Therapeutics Inc Stock (FHTX) is $4.1958 on average, with a high prediction of $8.3693 and a low estimate of $0.0224. This represents an -45.65% decrease from the previous price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.0931 | $7.7834 | $7.7231 | +4.83% |
| February, 2029 | $7.1854 | $8.4771 | $8.3693 | -6.92% |
| March, 2029 | $3.3478 | $4.7651 | $5.3435 | -56.64% |
| April, 2029 | $2.8201 | $3.2701 | $3.1158 | -63.47% |
| May, 2029 | $2.9005 | $4.5971 | $3.9143 | -62.43% |
| June, 2029 | $4.8928 | $3.5685 | $2.5728 | -36.62% |
| July, 2029 | $4.9849 | $1.017 | $5.7799 | -35.43% |
| August, 2029 | $1.8755 | $0.2907 | $8.2488 | -75.71% |
| September, 2029 | $5.1378 | $1.8735 | $2.6278 | -33.45% |
| October, 2029 | $1.1782 | $4.8582 | $5.2039 | -84.74% |
| November, 2029 | $0.7095 | $0.0224 | $2.1645 | -90.81% |
| December, 2029 | $3.8528 | $0.9266 | $2.3228 | -50.09% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2030
Foghorn Therapeutics Inc Stock (FHTX) is expected to reach an average price of $2.9915 in 2030, with a high forecast of $5.9808 and a low forecast of $0.00218. This signifies an -61.25% decrease from the last price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.7932 | $2.3751 | $3.9809 | -76.77% |
| February, 2030 | $0.6955 | $1.6855 | $1.0187 | -90.99% |
| March, 2030 | $0.2722 | $0.00218 | $1.9321 | -96.47% |
| April, 2030 | $1.9599 | $0.044 | $4.258 | -74.61% |
| May, 2030 | $4.8905 | $3.7563 | $2.9144 | -36.65% |
| June, 2030 | $5.8328 | $5.3348 | $4.4486 | -24.45% |
| July, 2030 | $4.4532 | $4.7651 | $4.7609 | -42.32% |
| August, 2030 | $5.5155 | $4.9813 | $5.3455 | -28.56% |
| September, 2030 | $6.0578 | $6.4036 | $5.8998 | -21.53% |
| October, 2030 | $3.5282 | $3.7082 | $5.2459 | -54.30% |
| November, 2030 | $6.2306 | $3.8563 | $5.5506 | -19.29% |
| December, 2030 | $6.3229 | $6.2167 | $5.9808 | -18.10% |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):